On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries
Current estimates suggest that 15% of all prisoners worldwide are chronically infected with the hepatitis C virus (HCV), and this number is even higher in regions with high rates of injecting drug use. Although harm reduction services such as opioid substitution therapy (OST) and needle and syringe programs (NSPs) are effective in preventing the further spread of HCV and HIV, the extent to which these are available in prisons varies significantly across countries.
The Global Fund Eligibility Policy and its impact on harm reduction funding
The Global Fund to Fight AIDS, TB and Malaria is the largest funder of harm reduction globally, but its eligibility policy currently precludes certain Upper Middle Income Countries (UMICs) from applying for funding.
Why access to morphine is a human right
"It’s easy to think of human rights as in some way innate, as something we and our ancestors have all simply been born with." says Jonathan Leighton, Executive Director, Organisation for the Prevention of Intense Suffering (OPIS)
Harm Reduction: More than just clean needles
Harm reduction is a realistic, pragmatic and non-judgmental approach based upon openness, understanding and respect.
Drug-related deaths in Scotland 1979–2013: evidence of a vulnerable cohort of young men living in deprived areas
Even after accounting for deprivation, mortality rates are higher in Scotland relative to the rest of Western Europe. Higher mortality from alcohol- and drug-related deaths (DRDs), violence and suicide (particularly in young adults) contribute to this ‘excess’ mortality.
‘Taking a New Line on Drugs’ assesses the situation in the UK as regards rising health harm from illegal drugs, with reference to their context within the wider ‘drugscape’ of legal drugs such as alcohol and tobacco, and sets out a new vision for a holistic public health-led approach to drugs policy at a UK-wide level.
UN Human Rights Council reaffirms role of human rights in international drug policy debate
Last Friday evening, 23 March 2018, the United Nations (UN) Human Rights Council concluded its 3-week long session by voting to adopt a Resolution reaffirming that human rights must play a central role in the ongoing international debate on global drug policies.
Eastern Africa makes strides towards balanced drug policies
Challenges related to the drugs trade in Eastern Africa are far from being resolved. While it used to be mostly a transit point, domestic demand is increasing. In 2012, Africa is estimated to have received about 9% of the global heroin trade.
High Commissioner’s global update of human rights concerns
Annual Report and Oral Update by the High Commissioner for Human Rights on the activities of his Office and recent human rights developments Statement by the UN High Commissioner for Human Rights, Zeid Ra'ad Al Hussein
Drug dependence treatment in Thailand: Progress against persistent concerns
In 2016, the Kingdom of Thailand formally de- cided to re-allocate responsibility for drug de- pendence treatment from the Ministry of Jus ce (MOJ) to the Ministry of Public Health (MOPH) by the end of 2018.
Share this on: